LISDEXAMFETAMINE IN CANADA : A COMPREHENSIVE OVERVIEW

Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in Canada for managing Attention-Deficit/Hyperactivity Dysfunction in youngsters and people. This functions as a prodrug, meaning it’s unchanged until metabolized by the body, releasing dextroamphetamine gradually over an exten